Clinical trial design for phase 1 studies of drug combinations

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)335-337
Number of pages3
JournalClinical Advances in Hematology and Oncology
Volume12
Issue number5
StatePublished - 2014

Fingerprint

Clinical Trials, Phase I
Drug Combinations
Combination Drug Therapy
Antineoplastic Agents
Research Design
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Hematology
  • Medicine(all)

Cite this

Clinical trial design for phase 1 studies of drug combinations. / Paller, Channing.

In: Clinical Advances in Hematology and Oncology, Vol. 12, No. 5, 2014, p. 335-337.

Research output: Contribution to journalArticle

@article{df749495cc394bc583c6a82f26f1113e,
title = "Clinical trial design for phase 1 studies of drug combinations",
author = "Channing Paller",
year = "2014",
language = "English (US)",
volume = "12",
pages = "335--337",
journal = "Nature Clinical Practice Oncology",
issn = "1759-4774",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Clinical trial design for phase 1 studies of drug combinations

AU - Paller, Channing

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84901828251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901828251&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 335

EP - 337

JO - Nature Clinical Practice Oncology

JF - Nature Clinical Practice Oncology

SN - 1759-4774

IS - 5

ER -